Perrigo (NYSE:PRGO – Get Free Report) issued an update on its FY25 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of $2.90-3.10 for the period, compared to the consensus estimate of $3.01. The company issued revenue guidance of +1-3% yr/yr to $4.42-4.51 billion, compared to the consensus revenue estimate of $4.62 billion.
Analyst Upgrades and Downgrades
Several research analysts have recently weighed in on the stock. Argus cut shares of Perrigo from a “buy” rating to a “hold” rating in a report on Tuesday, January 14th. StockNews.com lowered shares of Perrigo from a “buy” rating to a “hold” rating in a research note on Wednesday, February 19th. Finally, Piper Sandler downgraded Perrigo from an “overweight” rating to a “neutral” rating and dropped their price target for the stock from $34.00 to $27.00 in a research note on Monday, January 6th. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $35.00.
View Our Latest Research Report on PRGO
Perrigo Trading Down 3.3 %
Perrigo (NYSE:PRGO – Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The company reported $0.93 EPS for the quarter, topping analysts’ consensus estimates of $0.92 by $0.01. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. Sell-side analysts forecast that Perrigo will post 2.56 EPS for the current year.
Perrigo Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 25th. Shareholders of record on Friday, March 7th will be issued a dividend of $0.29 per share. The ex-dividend date is Friday, March 7th. This represents a $1.16 annualized dividend and a yield of 4.82%. This is an increase from Perrigo’s previous quarterly dividend of $0.28. Perrigo’s payout ratio is currently -99.15%.
Insiders Place Their Bets
In other news, Director Jeffrey B. Kindler sold 17,598 shares of the business’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $28.27, for a total value of $497,495.46. Following the transaction, the director now directly owns 5,409 shares in the company, valued at $152,912.43. The trade was a 76.49 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.40% of the company’s stock.
About Perrigo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
See Also
- Five stocks we like better than Perrigo
- What Are Dividend Champions? How to Invest in the Champions
- Why Smart Investors Are Watching These 3 Undervalued Stocks
- What is the Dogs of the Dow Strategy? Overview and Examples
- 3 Stocks Breaking Out with More Growth Potential Ahead
- What is the FTSE 100 index?
- Not Just China: 3 European Stocks Gaining Investor Interest
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.